Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass

R. A. Vertrees, W. Tao, George Kramer, L. Nutt, L. B. McDaniel, S. D. DeVine, G. Jesmok, J. B. Zwischenberger

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Tumor necrosis factor-α (TNF-α) has been implicated as causing the systemic inflammatory response to cardiopulmonary bypass (CPB) that contributes to the postoperative sequelae of coagulopathy, increased capillary permeability, leukocytosis, fever, and multiple organ dysfunction. To define the role of TNF-α on leukocyte populations during CPB, pigs (n = 6) were pretreated with 20 mg TNF-α monoclonal murine antibody before normothermic CPB (2 hr) in a blinded prospective randomized study with saline used as a control (n = 6). The leukocyte response to CPB was measured at 10, 30, 60, and 120 min during CPB and at 60 and 120 min after CPB. Repeated measures analysis of variance was performed and the null hypothesis was discarded at the 5% level. The control group displayed the typical leukocyte profile associated with CPB: an initial leukopenia (36% reduction) followed by leukocytosis (11% increase, P = 0.0001). The initial leukopenia was due to a fall in both polymorphonuclear neutrophils (33% reduced, P < 0.05) and monocytes (37% reduced, P < 0.05). In the TNF-α monoclonal murine antibody group the total leukocyte profile did not change significantly from baseline, (8.7% reduction to a 16% increase, P = 0.24) nor were there significant changes in populations including neutrophils and lymphocytes. In the treatment group the initial reduction in monocytes was prevented and total circulating monocytes increased during bypass. The experimental data suggest that TNF-α may play an important role in the early alterations in leukocyte populations associated with CPB, and TNF-α monoclonal murine antibody pretreatment ameliorates the leukocyte response.

Original languageEnglish (US)
JournalASAIO Journal
Volume40
Issue number3
StatePublished - Jul 1994

Fingerprint

Monoclonal antibodies
Cardiopulmonary Bypass
Leukocytes
Tumor Necrosis Factor-alpha
Monoclonal Antibodies
Population
Monocytes
Leukocytosis
Leukopenia
Neutrophils
Lymphocytes
Analysis of variance (ANOVA)
Capillary Permeability
Analysis of Variance
Fever
Swine
Prospective Studies
Control Groups

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Vertrees, R. A., Tao, W., Kramer, G., Nutt, L., McDaniel, L. B., DeVine, S. D., ... Zwischenberger, J. B. (1994). Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. ASAIO Journal, 40(3).

Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. / Vertrees, R. A.; Tao, W.; Kramer, George; Nutt, L.; McDaniel, L. B.; DeVine, S. D.; Jesmok, G.; Zwischenberger, J. B.

In: ASAIO Journal, Vol. 40, No. 3, 07.1994.

Research output: Contribution to journalArticle

Vertrees, RA, Tao, W, Kramer, G, Nutt, L, McDaniel, LB, DeVine, SD, Jesmok, G & Zwischenberger, JB 1994, 'Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass', ASAIO Journal, vol. 40, no. 3.
Vertrees, R. A. ; Tao, W. ; Kramer, George ; Nutt, L. ; McDaniel, L. B. ; DeVine, S. D. ; Jesmok, G. ; Zwischenberger, J. B. / Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass. In: ASAIO Journal. 1994 ; Vol. 40, No. 3.
@article{c4c5627ee66e49ecbee219765c9c75a4,
title = "Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass",
abstract = "Tumor necrosis factor-α (TNF-α) has been implicated as causing the systemic inflammatory response to cardiopulmonary bypass (CPB) that contributes to the postoperative sequelae of coagulopathy, increased capillary permeability, leukocytosis, fever, and multiple organ dysfunction. To define the role of TNF-α on leukocyte populations during CPB, pigs (n = 6) were pretreated with 20 mg TNF-α monoclonal murine antibody before normothermic CPB (2 hr) in a blinded prospective randomized study with saline used as a control (n = 6). The leukocyte response to CPB was measured at 10, 30, 60, and 120 min during CPB and at 60 and 120 min after CPB. Repeated measures analysis of variance was performed and the null hypothesis was discarded at the 5{\%} level. The control group displayed the typical leukocyte profile associated with CPB: an initial leukopenia (36{\%} reduction) followed by leukocytosis (11{\%} increase, P = 0.0001). The initial leukopenia was due to a fall in both polymorphonuclear neutrophils (33{\%} reduced, P < 0.05) and monocytes (37{\%} reduced, P < 0.05). In the TNF-α monoclonal murine antibody group the total leukocyte profile did not change significantly from baseline, (8.7{\%} reduction to a 16{\%} increase, P = 0.24) nor were there significant changes in populations including neutrophils and lymphocytes. In the treatment group the initial reduction in monocytes was prevented and total circulating monocytes increased during bypass. The experimental data suggest that TNF-α may play an important role in the early alterations in leukocyte populations associated with CPB, and TNF-α monoclonal murine antibody pretreatment ameliorates the leukocyte response.",
author = "Vertrees, {R. A.} and W. Tao and George Kramer and L. Nutt and McDaniel, {L. B.} and DeVine, {S. D.} and G. Jesmok and Zwischenberger, {J. B.}",
year = "1994",
month = "7",
language = "English (US)",
volume = "40",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass

AU - Vertrees, R. A.

AU - Tao, W.

AU - Kramer, George

AU - Nutt, L.

AU - McDaniel, L. B.

AU - DeVine, S. D.

AU - Jesmok, G.

AU - Zwischenberger, J. B.

PY - 1994/7

Y1 - 1994/7

N2 - Tumor necrosis factor-α (TNF-α) has been implicated as causing the systemic inflammatory response to cardiopulmonary bypass (CPB) that contributes to the postoperative sequelae of coagulopathy, increased capillary permeability, leukocytosis, fever, and multiple organ dysfunction. To define the role of TNF-α on leukocyte populations during CPB, pigs (n = 6) were pretreated with 20 mg TNF-α monoclonal murine antibody before normothermic CPB (2 hr) in a blinded prospective randomized study with saline used as a control (n = 6). The leukocyte response to CPB was measured at 10, 30, 60, and 120 min during CPB and at 60 and 120 min after CPB. Repeated measures analysis of variance was performed and the null hypothesis was discarded at the 5% level. The control group displayed the typical leukocyte profile associated with CPB: an initial leukopenia (36% reduction) followed by leukocytosis (11% increase, P = 0.0001). The initial leukopenia was due to a fall in both polymorphonuclear neutrophils (33% reduced, P < 0.05) and monocytes (37% reduced, P < 0.05). In the TNF-α monoclonal murine antibody group the total leukocyte profile did not change significantly from baseline, (8.7% reduction to a 16% increase, P = 0.24) nor were there significant changes in populations including neutrophils and lymphocytes. In the treatment group the initial reduction in monocytes was prevented and total circulating monocytes increased during bypass. The experimental data suggest that TNF-α may play an important role in the early alterations in leukocyte populations associated with CPB, and TNF-α monoclonal murine antibody pretreatment ameliorates the leukocyte response.

AB - Tumor necrosis factor-α (TNF-α) has been implicated as causing the systemic inflammatory response to cardiopulmonary bypass (CPB) that contributes to the postoperative sequelae of coagulopathy, increased capillary permeability, leukocytosis, fever, and multiple organ dysfunction. To define the role of TNF-α on leukocyte populations during CPB, pigs (n = 6) were pretreated with 20 mg TNF-α monoclonal murine antibody before normothermic CPB (2 hr) in a blinded prospective randomized study with saline used as a control (n = 6). The leukocyte response to CPB was measured at 10, 30, 60, and 120 min during CPB and at 60 and 120 min after CPB. Repeated measures analysis of variance was performed and the null hypothesis was discarded at the 5% level. The control group displayed the typical leukocyte profile associated with CPB: an initial leukopenia (36% reduction) followed by leukocytosis (11% increase, P = 0.0001). The initial leukopenia was due to a fall in both polymorphonuclear neutrophils (33% reduced, P < 0.05) and monocytes (37% reduced, P < 0.05). In the TNF-α monoclonal murine antibody group the total leukocyte profile did not change significantly from baseline, (8.7% reduction to a 16% increase, P = 0.24) nor were there significant changes in populations including neutrophils and lymphocytes. In the treatment group the initial reduction in monocytes was prevented and total circulating monocytes increased during bypass. The experimental data suggest that TNF-α may play an important role in the early alterations in leukocyte populations associated with CPB, and TNF-α monoclonal murine antibody pretreatment ameliorates the leukocyte response.

UR - http://www.scopus.com/inward/record.url?scp=0028464334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028464334&partnerID=8YFLogxK

M3 - Article

VL - 40

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -